{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:12:26Z","timestamp":1790255546630,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25037190"],"award-info":[{"award-number":["R25037190"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12041449"],"award-info":[{"award-number":["K12041449"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA057136"],"award-info":[{"award-number":["R21DA057136"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA045738"],"award-info":[{"award-number":["K01DA045738"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with opioid use disorders (OUD) living in the South and Midwest are under-prescribed pre-exposure prophylaxis (PrEP) despite an increasing number of providers writing PrEP prescriptions in other regions of the United States. Greater research is needed into attitudes toward integrating harm reduction strategies into primary care and PrEP prescribing among prescribers working in rural primary care settings. The objective of this paper was to examine relationships between providers\u2019 attitudes toward buprenorphine and methadone, comprehensive harm reduction (e.g., fentanyl test strips) and self-reported PrEP prescribing in the past year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Relationships were examined between attitudes toward buprenorphine and harm reduction services, and PrEP prescribing among 409 rural primary health care providers (PCPs) treating at least one person with OUD or HIV in several EHE priority states. A Qualtrics panel survey was administered to primary care providers residing in the U.S. South and Midwest and worked in a Federally Qualified Health Center, Rural Health Clinic or other HRSA-eligible health center. Chi-square tests were used to explore significant differences between PrEP prescribers and non-Prescribers on attitudes toward integrating MOUD, drug-related harm reduction into primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 62.1% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009254) of the sample of providers reported writing at least one prescription for PrEP in the past year. Providers who believed that reforming buprenorphine waiver laws made their jobs easier or who expressed interest in integrating naloxone distribution and syringe exchange into primary care were more likely to write prescriptions for PrEP compared to providers who did not have these beliefs. Providers who were from larger facilities and who had specialty training in infectious diseases were more likely to write prescriptions for PrEP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings from this study suggest that providers who are more open to integrating harm reduction services into primary care are more likely to prescribe PrEP in the past year. PCPs with more positive attitudes toward naloxone, syringe exchange, and buprenorphine were more likely to prescribe PrEP in the past year. Combination interventions may be a promising avenue of reducing the harms of drug use including overdose and HIV infection among populations of people who use drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-025-00584-9","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T09:44:08Z","timestamp":1757670248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rural providers\u2019 attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5799-1736","authenticated-orcid":false,"given":"Phillip L.","family":"Marotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Biaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Heimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Reno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Winograd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Goddard-Eckrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Filiatreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaileigh","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cavazos-Rehg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","unstructured":"Murphy M, Rogers BG, Ames E, et al. Implementing preexposure prophylaxis for HIV prevention in a statewide correctional system in the united States. Public Health Rep Published Online July. 2023;21. https:\/\/doi.org\/10.1177\/00333549231186576.","DOI":"10.1177\/00333549231186576"},{"issue":"6","key":"584_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/S11904-017-0367-7","volume":"14","author":"IB Zablotska","year":"2017","unstructured":"Zablotska IB, O\u2019Connor CC. Preexposure prophylaxis of HIV infection: the role of clinical practices in ending the HIV epidemic. Curr HIV\/AIDS Rep. 2017;14(6):201\u201310. https:\/\/doi.org\/10.1007\/S11904-017-0367-7.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"584_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"YI Hser","year":"2014","unstructured":"Hser YI, Saxon AJ, Huang D, et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79\u201387. https:\/\/doi.org\/10.1111\/add.12333.","journal-title":"Addiction"},{"key":"584_CR4","first-page":"1","volume":"61RR\u20135","author":"Centers for Disease Control","year":"2012","unstructured":"Centers for Disease Control. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of health and human services. MMWR Recommendations Reports: Morbidity Mortal Wkly Rep Recommendations Rep \/ Centers Disease Control. 2012;61RR\u20135:1\u201340.","journal-title":"MMWR Recommendations Reports: Morbidity Mortal Wkly Rep Recommendations Rep \/ Centers Disease Control"},{"issue":"4","key":"584_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1521\/AEAP.2021.33.4.325","volume":"33","author":"ED Storholm","year":"2021","unstructured":"Storholm ED, Ober AJ, Mizel ML, et al. Primary care providers\u2019 knowledge, attitudes, and beliefs about HIV Pre-Exposure prophylaxis (PrEP): informing Network-Based interventions. AIDS Educ Prev. 2021;33(4):325\u201344. https:\/\/doi.org\/10.1521\/AEAP.2021.33.4.325.","journal-title":"AIDS Educ Prev"},{"key":"584_CR6","doi-asserted-by":"publisher","unstructured":"Ojikutu BO, Bogart LM, Mayer KH, Stopka TJ, Sullivan PS, Ransome Y. Spatial access and willingness to use Pre-Exposure prophylaxis among black\/african American individuals in the united states: Cross-Sectional survey. JMIR Public Health Surveill. 2019;5(1). https:\/\/doi.org\/10.2196\/12405.","DOI":"10.2196\/12405"},{"issue":"12","key":"584_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/J.ANNEPIDEM.2018.05.003","volume":"28","author":"DK Smith","year":"2018","unstructured":"Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race\/ethnicity, united states, 2015. Ann Epidemiol. 2018;28(12):850\u2013e8579. https:\/\/doi.org\/10.1016\/J.ANNEPIDEM.2018.05.003.","journal-title":"Ann Epidemiol"},{"issue":"9","key":"584_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/JAMA.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: A plan for the united States. JAMA. 2019;321(9):844\u20135. https:\/\/doi.org\/10.1001\/JAMA.2019.1343.","journal-title":"JAMA"},{"issue":"1","key":"584_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2105\/AJPH.2019.305380","volume":"110","author":"BP Giroir","year":"2020","unstructured":"Giroir BP. The time is now to end the HIV epidemic. Am J Public Health. 2020;110(1):22\u20134. https:\/\/doi.org\/10.2105\/AJPH.2019.305380.","journal-title":"Am J Public Health"},{"issue":"6","key":"584_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/S10461-020-03120-9","volume":"25","author":"JM Sales","year":"2021","unstructured":"Sales JM, Escoffery C, Hussen SA, et al. Pre-exposure prophylaxis implementation in family planning services across the Southern united states: findings from a survey among staff, providers and administrators working in title X-Funded clinics. AIDS Behav. 2021;25(6):1901\u201312. https:\/\/doi.org\/10.1007\/S10461-020-03120-9.","journal-title":"AIDS Behav"},{"issue":"1","key":"584_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/FAMPRA\/CMAC081","volume":"40","author":"A Townes","year":"2023","unstructured":"Townes A, Gaul Z, Henny KD. Sexual health discussion practices and HIV clinical care provided by primary care providers in the Southeast united states, K-BAP study (2017\u20132018). Fam Pract. 2023;40(1):39\u201346. https:\/\/doi.org\/10.1093\/FAMPRA\/CMAC081.","journal-title":"Fam Pract"},{"key":"584_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/FPUBH.2020.00210\/FULL","volume":"8","author":"AD Bagchi","year":"2020","unstructured":"Bagchi AD. A structural competency curriculum for primary care providers to address the opioid use disorder, hiv, and hepatitis c syndemic. Front Public Health. 2020;8:210. https:\/\/doi.org\/10.3389\/FPUBH.2020.00210\/FULL.","journal-title":"Front Public Health"},{"issue":"3","key":"584_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/S12529-020-09925-1","volume":"28","author":"MC Sullivan","year":"2021","unstructured":"Sullivan MC, Eaton LA. Intersecting barriers to PrEP awareness and uptake in black men who have sex with men in atlanta, GA: a syndemic perspective. Int J Behav Med. 2021;28(3):349\u201359. https:\/\/doi.org\/10.1007\/S12529-020-09925-1.","journal-title":"Int J Behav Med"},{"key":"584_CR14","doi-asserted-by":"publisher","unstructured":"Rogers BG, Murphy M, Zanowick-Marr A, et al. Characterizing HIV syndemics and the role of incarceration among men who have sex with men presenting for care at a sexually transmitted infections clinic. AIDS Behav. 2023;27(8). https:\/\/doi.org\/10.1007\/S10461-023-03978-5.","DOI":"10.1007\/S10461-023-03978-5"},{"issue":"10279","key":"584_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(21)00390-1","volume":"397","author":"C Beyrer","year":"2021","unstructured":"Beyrer C, Adimora AA, Hodder SL, et al. Call to action: how can the US ending the HIV epidemic initiative succeed? Lancet. 2021;397(10279):1151\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(21)00390-1.","journal-title":"Lancet"},{"issue":"7","key":"584_CR16","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton BR, Grulich AE. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health. 2021;6(7):e528\u201333. https:\/\/doi.org\/10.1016\/S2468-2667(21)00112-2.","journal-title":"Lancet Public Health"},{"issue":"6","key":"584_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.2105\/AJPH.2012.301129","volume":"103","author":"JA Frimpong","year":"2013","unstructured":"Frimpong JA. Missed opportunities for hepatitis c testing in opioid treatment programs. Am J Public Health. 2013;103(6):1028\u201330. https:\/\/doi.org\/10.2105\/AJPH.2012.301129.","journal-title":"Am J Public Health"},{"key":"584_CR18","doi-asserted-by":"publisher","unstructured":"Jayasekera CR, Perumpail RB, Chao DT et al. Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas. Digestive Diseases and Sciences. 2015;60(12):3552\u20133557. https:\/\/doi.org\/10.1007\/S10620-015-3911-6","DOI":"10.1007\/S10620-015-3911-6"},{"issue":"8","key":"584_CR19","doi-asserted-by":"publisher","first-page":"e2327488","DOI":"10.1001\/JAMANETWORKOPEN.2023.27488","volume":"6","author":"CM Jones","year":"2023","unstructured":"Jones CM, Han B, Baldwin GT, Einstein EB, Compton WM. Use of medication for opioid use disorder among adults with Past-Year opioid use disorder in the US, 2021. JAMA Netw Open. 2023;6(8):e2327488\u20132327488. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.27488.","journal-title":"JAMA Netw Open"},{"key":"584_CR20","doi-asserted-by":"publisher","unstructured":"Poliwoda S, Noor N, Jenkins JS, et al. Buprenorphine and its formulations: a comprehensive review. Health Psychol Res. 2022;10(3). https:\/\/doi.org\/10.52965\/001C.37517.","DOI":"10.52965\/001C.37517"},{"key":"584_CR21","doi-asserted-by":"publisher","unstructured":"Lai B, Croghan I, Ebbert JO. Buprenorphine waiver attitudes among primary care providers. J Prim Care Community Health. 2022;13. https:\/\/doi.org\/10.1177\/21501319221112272.","DOI":"10.1177\/21501319221112272"},{"key":"584_CR22","unstructured":"Become a Buprenorphine Waivered Practitioner | SAMHSA. Accessed January 1. 2022. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/become-buprenorphine-waivered-practitioner"},{"issue":"3","key":"584_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","volume":"46","author":"JJ Lister","year":"2020","unstructured":"Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the united States. Am J Drug Alcohol Abuse. 2020;46(3):273\u201388. https:\/\/doi.org\/10.1080\/00952990.2019.1694536.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"584_CR24","doi-asserted-by":"publisher","unstructured":"Green TC, Bratberg J, Baird J, et al. Rurality and differences in pharmacy characteristics and community factors associated with provision of Naloxone in the pharmacy. Int J Drug Policy. 2020;85. https:\/\/doi.org\/10.1016\/J.DRUGPO.2019.11.010.","DOI":"10.1016\/J.DRUGPO.2019.11.010"},{"key":"584_CR25","unstructured":"USDA ERS - What is Rural? Accessed January 1. 2022. https:\/\/www.ers.usda.gov\/topics\/rural-economy-population\/rural-classifications\/what-is-rural\/"},{"key":"584_CR26","unstructured":"Rural Health Grants Eligibility Analyzer. Accessed August 31. 2023. https:\/\/data.hrsa.gov\/tools\/rural-health"},{"key":"584_CR27","unstructured":"Rural Health Clinics (RHCs) Overview - Rural Health Information Hub. Accessed August 31. 2023. https:\/\/www.ruralhealthinfo.org\/topics\/rural-health-clinics"},{"key":"584_CR28","unstructured":"Shaver C, Johnson J, \u2026 RGJ of H, 2021 undefined. Comparative analysis of state level health policy support for opioid abuse mitigation in rural America. search.proquest.comCS Shaver, JA Johnson, RG Greenhill, S NadimidlaJournal of Health and Human Services Administration, 2021\u2022search.proquest.com. Accessed August 30, 2023. https:\/\/search.proquest.com\/openview\/e50e0bc69a2da4918a8cda28cb9d9671\/1?pq-origsite=gscholar%26cbl=27394%26casa_token=pICD7mHSmuUAAAAA:zhzufaG923T7Ic9PwIz8yFcSAAUP4Cxt7zj93NHepOIDS9ZJoVJ7sd7xE9IX4nMFHp2XZ8hfj_jz."},{"issue":"3","key":"584_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","volume":"46","author":"JJ Lister","year":"2020","unstructured":"Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM, Weaver A, Ellis JD, Himle JA. DM LedgerwoodThe Am J Drug Alcohol Abuse 2020\u2022Taylor Francis. 2020;46(3):273\u201388. https:\/\/doi.org\/10.1080\/00952990.2019.1694536.","journal-title":"DM LedgerwoodThe Am J Drug Alcohol Abuse 2020\u2022Taylor Francis"},{"key":"584_CR30","doi-asserted-by":"publisher","unstructured":"Harder VS, Villanti AC, Heil SH, et al. Opioid use disorder treatment in rural settings: the primary care perspective. Prev Med (Baltim). 2021;152(Pt 2). https:\/\/doi.org\/10.1016\/J.YPMED.2021.106765.","DOI":"10.1016\/J.YPMED.2021.106765"},{"key":"584_CR31","doi-asserted-by":"publisher","unstructured":"Hall NY, Le L, Majmudar I, Mihalopoulos C. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug Alcohol Depend. 2021;221. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2021.108651.","DOI":"10.1016\/J.DRUGALCDEP.2021.108651"},{"key":"584_CR32","doi-asserted-by":"publisher","unstructured":"Albright DL, Johnson K, Laha-Walsh K, Mcdaniel J, Mcintosh S. Social determinants of opioid use among patients in rural primary care settings., Taylor, Albright FDL, Johnson K, Laha-Walsh K, McDaniel J. S McIntoshSocial Work in Public Health, 2021\u2022Taylor & Francis. 2021;36(6):723\u2013731. https:\/\/doi.org\/10.1080\/19371918.2021.1939831","DOI":"10.1080\/19371918.2021.1939831"},{"issue":"2","key":"584_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/JRH.12723","volume":"39","author":"C Owens","year":"2023","unstructured":"Owens C. HIV pre-exposure prophylaxis awareness, practices, and comfort among urban and rural family medicine physicians. J Rural Health. 2023;39(2):469\u201376. https:\/\/doi.org\/10.1111\/JRH.12723.","journal-title":"J Rural Health"},{"issue":"sup3","key":"584_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09540121.2018.1479030","volume":"30","author":"M Swann","year":"2018","unstructured":"Swann M. Economic strengthening for retention in HIV care and adherence to antiretroviral therapy: a review of the evidence. AIDS Care. 2018;30(sup3):99\u2013125. https:\/\/doi.org\/10.1080\/09540121.2018.1479030.","journal-title":"AIDS Care"},{"issue":"1","key":"584_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/JRH.12491","volume":"37","author":"WL Swann","year":"2021","unstructured":"Swann WL, Kim S, Kim SY, Schreiber TL. Urban-Rural disparities in opioid use disorder prevention and response activities: A Cross-Sectional analysis. J Rural Health. 2021;37(1):16\u201322. https:\/\/doi.org\/10.1111\/JRH.12491.","journal-title":"J Rural Health"},{"key":"584_CR36","unstructured":"Hall N, Le L, Majmudar I. dependence CMD and alcohol, 2021 undefined. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Elsevier. Accessed August 30, 2023. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0376871621001460?casa_token=7iuHl853f6gAAAAA:ghItnOTH_9DtrdIHD4fqhIMuwbWM8XnE6cE4uf-g9tazza_Ewb2dMkQiDelYjfyjLzHsIMse0eM7"},{"issue":"4","key":"584_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/S10461-021-03488-2","volume":"26","author":"SM Walters","year":"2022","unstructured":"Walters SM, Frank D, Van Ham B, et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2022;26(4):1308\u201320. https:\/\/doi.org\/10.1007\/S10461-021-03488-2.","journal-title":"AIDS Behav"},{"issue":"4","key":"584_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/COH.0000000000000628","volume":"15","author":"E Mendenhall","year":"2020","unstructured":"Mendenhall E, Singer M. What constitutes a syndemic? Methods, contexts, and framing from 2019. Curr Opin HIV AIDS. 2020;15(4):213\u20137. https:\/\/doi.org\/10.1097\/COH.0000000000000628.","journal-title":"Curr Opin HIV AIDS"},{"key":"584_CR39","unstructured":"Singer M. Chapter 8: A World Out of Balance. Introduction to syndemics: a critical systems approach to public and community health. Published online 2009:177\u2013196. Accessed July 30, 2023. https:\/\/www.wiley.com\/en-us\/Introduction+to+Syndemics%3A+A+Critical+Systems+Approach+to+Public+and+Community+Health-p-9780470472033"},{"key":"584_CR40","doi-asserted-by":"publisher","unstructured":"Himmelgreen D, Romero-Daza N, Heuer J, Lucas W, Salinas-Miranda AA, Stoddard T. Using syndemic theory to understand food insecurity and diet-related chronic diseases. Soc Sci Med. 2022;295. https:\/\/doi.org\/10.1016\/J.SOCSCIMED.2020.113124.","DOI":"10.1016\/J.SOCSCIMED.2020.113124"},{"issue":"1","key":"584_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/JAMA.2021.22583","volume":"327","author":"KE Rudd","year":"2022","unstructured":"Rudd KE, Mair CF, Angus DC. Applying syndemic theory to acute illness. JAMA. 2022;327(1):33\u20134. https:\/\/doi.org\/10.1001\/JAMA.2021.22583.","journal-title":"JAMA"},{"issue":"1","key":"584_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/S11904-010-0063-3","volume":"8","author":"AE Kurth","year":"2011","unstructured":"Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV\/AIDS Rep. 2011;8(1):62\u201372. https:\/\/doi.org\/10.1007\/S11904-010-0063-3.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9737","key":"584_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","volume":"376","author":"L Degenhardt","year":"2010","unstructured":"Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285\u2013301. https:\/\/doi.org\/10.1016\/S0140-6736(10)60742-8.","journal-title":"Lancet"},{"issue":"4","key":"584_CR44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/COH.0B013E32835369AD","volume":"7","author":"SA Strathdee","year":"2012","unstructured":"Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS. 2012;7(4):320. https:\/\/doi.org\/10.1097\/COH.0B013E32835369AD.","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"584_CR45","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1007\/S10461-017-1965-5","volume":"21","author":"TA Sipe","year":"2017","unstructured":"Sipe TA, Barham TL, Johnson WD, Joseph HA, Tungol-Ashmon ML, O\u2019Leary A. Structural interventions in HIV prevention: A taxonomy and descriptive systematic review. AIDS Behav. 2017;21(12):3366\u2013430. https:\/\/doi.org\/10.1007\/S10461-017-1965-5.","journal-title":"AIDS Behav"},{"key":"584_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JSAT.2017.04.005","volume":"78","author":"AS Huhn","year":"2017","unstructured":"Huhn AS, Dunn KE. Why aren\u2019t physicians prescribing more buprenorphine?? J Subst Abuse Treat. 2017;78:1. https:\/\/doi.org\/10.1016\/J.JSAT.2017.04.005.","journal-title":"J Subst Abuse Treat"},{"key":"584_CR47","doi-asserted-by":"publisher","unstructured":"Ellis MS, Buttram ME, Editorial. Broadening the scope of addiction medicine: integrating co-morbid conditions, polysubstance use, and patient experiences into substance use treatment. Front Psychiatry. 2022;13. https:\/\/doi.org\/10.3389\/FPSYT.2022.1049420.","DOI":"10.3389\/FPSYT.2022.1049420"},{"key":"584_CR48","doi-asserted-by":"publisher","unstructured":"Donroe JH, Bhatraju EP, Tsui JI, Edelman EJ. Identification and management of opioid use disorder in primary care: an update. Curr Psychiatry Rep. 2020;22(5). https:\/\/doi.org\/10.1007\/S11920-020-01149-0.","DOI":"10.1007\/S11920-020-01149-0"},{"issue":"9","key":"584_CR49","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1176\/APPI.AJP.2021.20101548","volume":"178","author":"D McCarty","year":"2021","unstructured":"McCarty D, Bougatsos C, Chan B, et al. Office-Based methadone treatment for opioid use disorder and pharmacy dispensing: A scoping review. Am J Psychiatry. 2021;178(9):804\u201317. https:\/\/doi.org\/10.1176\/APPI.AJP.2021.20101548.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"584_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-023-00834-6\/TABLES\/1","volume":"20","author":"Y An","year":"2023","unstructured":"An Y, Hoffmann CJ, Bhoora U, et al. Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South africa: a qualitative study. Harm Reduct J. 2023;20(1):1\u201310. https:\/\/doi.org\/10.1186\/S12954-023-00834-6\/TABLES\/1.","journal-title":"Harm Reduct J"},{"key":"584_CR51","doi-asserted-by":"crossref","unstructured":"Mistler CB, Rosen AO, Eger W, Copenhaver MM, Shrestha R. Fentanyl Test Strip Use and Overdose History among Individuals on Medication for Opioid Use Disorder. Austin journal of public health and epidemiology. 2021;8(5). Accessed August 30, 2023. \/pmc\/articles\/PMC9249264\/.","DOI":"10.26420\/AustinJPublicHealthEpidemiol.2021.1117"},{"issue":"4","key":"584_CR52","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/08897077.2021.1915915","volume":"42","author":"J Ko","year":"2021","unstructured":"Ko J, Chan E, Doroudgar S. Patient perspectives of barriers to Naloxone obtainment and use in a primary care, underserved setting: A qualitative study. Subst Abus. 2021;42(4):1030\u20139. https:\/\/doi.org\/10.1080\/08897077.2021.1915915.","journal-title":"Subst Abus"},{"key":"584_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.YPMED.2018.06.005","volume":"114","author":"E Behar","year":"2018","unstructured":"Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of Naloxone prescribing in primary care settings: A systematic review. Prev Med (Baltim). 2018;114:79. https:\/\/doi.org\/10.1016\/J.YPMED.2018.06.005.","journal-title":"Prev Med (Baltim)"},{"issue":"5","key":"584_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1370\/AFM.1972","volume":"14","author":"E Behar","year":"2016","unstructured":"Behar E, Rowe C, Santos GM, Murphy S, Coffin PO. Primary care patient experience with Naloxone prescription. Ann Fam Med. 2016;14(5):431\u20136. https:\/\/doi.org\/10.1370\/AFM.1972.","journal-title":"Ann Fam Med"},{"issue":"1","key":"584_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/JAMAINTERNMED.2019.5456","volume":"180","author":"J Khalili","year":"2020","unstructured":"Khalili J, Landovitz RJ. HIV preexposure Prophylaxis-The role of primary care clinicians in ending the HIV epidemic. JAMA Intern Med. 2020;180(1):126\u201330. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2019.5456.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"584_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08897077.2017.1389802","volume":"39","author":"HE Jack","year":"2018","unstructured":"Jack HE, Oller D, Kelly J, Magidson JF, Wakeman SE. Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches. Subst Abus. 2018;39(3):307\u201314. https:\/\/doi.org\/10.1080\/08897077.2017.1389802.","journal-title":"Subst Abus"},{"issue":"2","key":"584_CR57","first-page":"109","volume":"99","author":"AJ Visconti","year":"2019","unstructured":"Visconti AJ, Sell J, Greenblatt AD. Primary care for persons who inject drugs. Am Fam Physician. 2019;99(2):109\u201316. https:\/\/www.aafp.org\/pubs\/afp\/issues\/2019\/0115\/p109.html. Accessed August 31, 2023.","journal-title":"Am Fam Physician"},{"key":"584_CR58","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences E. Opportunities to improve opioid use disorder and infectious disease services: integrating responses to a dual epidemic. Opportunities to improve opioid use disorder and infectious disease services. Published Online January. 2020;23. https:\/\/doi.org\/10.17226\/25626.","DOI":"10.17226\/25626"},{"issue":"5","key":"584_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M18-1203","volume":"169","author":"SA Springer","year":"2018","unstructured":"Springer SA, Korthuis PT, del Rio C. Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: A call for action after a National academies of sciences, engineering, and medicine workshop. Ann Intern Med. 2018;169(5):335\u20136. https:\/\/doi.org\/10.7326\/M18-1203.","journal-title":"Ann Intern Med"},{"issue":"1","key":"584_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-020-05568-W\/FIGURES\/5","volume":"20","author":"J Vanhamel","year":"2020","unstructured":"Vanhamel J, Rotsaert A, Reyniers T, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: A scoping review Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): A scoping review on PrEP service delivery and programming. BMC Health Serv Res. 2020;20(1):1\u201318. https:\/\/doi.org\/10.1186\/S12913-020-05568-W\/FIGURES\/5.","journal-title":"BMC Health Serv Res"},{"key":"584_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-59745-530-5_3","volume":"404","author":"TG Nick","year":"2007","unstructured":"Nick TG. Descriptive statistics. Methods Mol Biol. 2007;404:33\u201352. https:\/\/doi.org\/10.1007\/978-1-59745-530-5_3.","journal-title":"Methods Mol Biol"},{"key":"584_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4324\/9780429056765-8","volume":"6","author":"D George","year":"2019","unstructured":"George D, Mallery P, Descriptive Statistics. IBM SPSS statistics 26 step by step. Published Online Dec. 2019;6:112\u201320. https:\/\/doi.org\/10.4324\/9780429056765-8.","journal-title":"Published Online Dec"},{"key":"584_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/9781108654555.006","volume":"1","author":"P Haden","year":"2019","unstructured":"Haden P. Descriptive statistics. The Cambridge handbook of computing education research. Published Online January. 2019;1:102\u201332. https:\/\/doi.org\/10.1017\/9781108654555.006.","journal-title":"Published Online January"},{"key":"584_CR64","doi-asserted-by":"publisher","unstructured":"Lindenfeld Z, Hagan H, Chang JE. Exploring barriers and facilitators to integrating a harm reduction approach to substance use in three medical settings. J Gen Intern Med. 2023;38(15). https:\/\/doi.org\/10.1007\/s11606-023-08231-2.","DOI":"10.1007\/s11606-023-08231-2"},{"key":"584_CR65","doi-asserted-by":"publisher","unstructured":"Heller D, McCoy K, Cunningham C. An invisible barrier to integrating HIV primary care with harm reduction services: philosophical clashes between the harm reduction and medical models. Public Health Rep. 2004;119(1). https:\/\/doi.org\/10.1177\/003335490411900109.","DOI":"10.1177\/003335490411900109"},{"key":"584_CR66","doi-asserted-by":"publisher","unstructured":"Hawk ME, Chung A, Creasy SL, Egan JE. A scoping review of patient preferences for HIV self-testing services in the united states: implications for harm reduction. Patient Prefer Adherence. 2020;14. https:\/\/doi.org\/10.2147\/PPA.S251677.","DOI":"10.2147\/PPA.S251677"},{"key":"584_CR67","doi-asserted-by":"publisher","unstructured":"Barnett AP, Arnold T, Elwy AR, CONSIDERATIONS FOR PREP IMPLEMENTATION AT FEDERALLY QUALIFIED HEALTH CENTERS IN MISSISSIPPI: PERSPECTIVES FROM STAFF AND PATIENTS, et al. AIDS Educ Prev. 2023;35(4). https:\/\/doi.org\/10.1521\/aeap.2023.35.4.309.","DOI":"10.1521\/aeap.2023.35.4.309"},{"key":"584_CR68","doi-asserted-by":"publisher","unstructured":"Clement ME, Johnston BE, Eagle C, et al. Advancing the HIV Pre-Exposure prophylaxis continuum: A collaboration between a public health department and a federally qualified health center in the Southern united States. AIDS Patient Care STDS. 2019;33(8). https:\/\/doi.org\/10.1089\/apc.2019.0054.","DOI":"10.1089\/apc.2019.0054"},{"key":"584_CR69","doi-asserted-by":"publisher","unstructured":"Chan K, Mitchell MM, Casselle E, Bender AA, FACILITATORS AND BARRIERS TO PrEP ACCEPTABILITY, AND INITIATION AMONG OPIOID TREATMENT PROGRAM PATIENTS AND STAFF. AIDS Educ Prev. 2024;36(1). https:\/\/doi.org\/10.1521\/aeap.2024.36.1.60.","DOI":"10.1521\/aeap.2024.36.1.60"},{"key":"584_CR70","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.21352","author":"R Bhandari","year":"2022","unstructured":"Bhandari R. HIV preexposure prophylaxis among people with substance use Disorder - The road less traveled. JAMA Netw Open Published Online. 2022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.21352.","journal-title":"JAMA Netw Open Published Online"},{"issue":"1","key":"584_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1049732320952740","volume":"31","author":"M Felsher","year":"2021","unstructured":"Felsher M, Koku E, Lankenau S, Brady K, Bellamy S, Roth AM. Motivations for PrEP-Related interpersonal communication among women who inject drugs: A qualitative egocentric network study. Qual Health Res. 2021;31(1):86\u201399. https:\/\/doi.org\/10.1177\/1049732320952740.","journal-title":"Qual Health Res"},{"issue":"3","key":"584_CR72","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/S11606-019-05475-9","volume":"35","author":"AA Skolnik","year":"2020","unstructured":"Skolnik AA, Bokhour BG, Gifford AL, Wilson BM, Van Epps P. Roadblocks to prep: what medical records reveal about access to HIV Pre-exposure prophylaxis. J Gen Intern Med. 2020;35(3):832\u20138. https:\/\/doi.org\/10.1007\/S11606-019-05475-9.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"584_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","volume":"16","author":"PS Sullivan","year":"2019","unstructured":"Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South. Curr HIV\/AIDS Rep. 2019;16(4):259\u201369. https:\/\/doi.org\/10.1007\/s11904-019-00447-4.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"584_CR74","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","volume":"22","author":"RM Pinto","year":"2018","unstructured":"Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS Behav. 2018;22(11):3681\u201391. https:\/\/doi.org\/10.1007\/s10461-018-2184-4.","journal-title":"AIDS Behav"},{"key":"584_CR75","doi-asserted-by":"publisher","unstructured":"Lin T, Chen CH, Chou P. Effects of combination approach on harm reduction programs:The Taiwan experience. Harm Reduct J. 2016;13(1):1\u201310. https:\/\/doi.org\/10.1186\/S12954-016-0112-3\/FIGURES\/5.","DOI":"10.1186\/S12954-016-0112-3\/FIGURES\/5"},{"key":"584_CR76","unstructured":"Grossman C, \u2026 DPA, 2013 undefined. Opportunities for HIV combination prevention to reduce racial and ethnic health disparities. psycnet.apa.org. Accessed April 17, 2021. https:\/\/psycnet.apa.org\/record\/2013-17443-004."}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00584-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T09:44:12Z","timestamp":1757670252000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-025-00584-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00584-9","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained electronically followed by an online self-administered anonymous survey that took on average approximately 45\u00a0min to complete. No identifiable information, including IP addresses, was collected ensuring respondent privacy. The Washington University and Yale University Institutional Review Boards approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}